This is actually the type of heart attack that occurswhena vessel providing blood to the center is suddenly and completely blocked. Research demonstrates the earlier a blocked artery can be re-opened, the more likely the patient shall survive and the much less severe their coronary attack will be. This initiative will be completed over the next 2 yrs in 14 regions of the country. Metropolitan regions will be able to obtain a regional award. Acceptance will end up being announced in early March, 2015. This task shall build on the achievement of the originalSTEMI ACCELERATOR project, which demonstrated that collaboration between paramedics and hospitals in dealing with heart attack patients led to shorter emergency division wait times that eventually reduced death rates.This study is being conducted at 22 sites in data and India will be presented on 109 out from the planned 110 patients enrolled by Might 18, 2012. The primary efficacy endpoint of this study is overall survival. In preliminary data to end up being offered by Dr. Robert Petit, VP of Clinical Operations and Medical Affairs at Advaxis, by May 18, 2012: 109 patients have obtained 255 doses of ADVS-HPV, The tolerability of ADXS-HPV weighed against solitary agent and favorably combination chemotherapies energetic in this disease establishing, with 36 percent of patients experiencing Grade 1-2 adverse occasions related/possibly linked to ADXS-HPV and 0.9 percent suffering from a Grade 3 serious adverse event, Survival at 6, 9, and 12 months is normally 65 percent, 40 percent, and 31 percent, respectively.